What legal challenges might GPs pursue over price display rules?

Question

Accepted Answer

GPs May Pursue Legal Challenges Over Medication Price Display Rules

Private general practitioners (GPs) are considering legal action, specifically through judicial review, to challenge the mandatory display of medication prices in their clinics. This potential legal recourse stems from the Federation of Private Medical Practitioners Associations Malaysia's (FPMPAM) belief that applying the Price Control and Anti-Profiteering Act 2011 to healthcare services is fundamentally flawed. They argue that medical practice is primarily governed by the Private Healthcare Facilities and Services Act (PHFSA) 1998, creating a conflict in pricing regulations.
Judicial Review as a Potential Legal Pathway

The FPMPAM has indicated that pursuing legal action through judicial review is a necessary and critical measure to protect the interests of GPs. Judicial review is a legal process where a court reviews the lawfulness of a decision or action made by a public body. In this context, GPs might seek to have the mandatory price display rule, implemented under the Price Control and Anti-Profiteering Act 2011, reviewed by the courts to assess its legality and compliance with existing healthcare legislation.
Conflict Between Healthcare and Price Control Legislation

A core argument against the mandatory price display rule centers on the perceived conflict between two pieces of legislation: the Price Control and Anti-Profiteering Act 2011 and the Private Healthcare Facilities and Services Act (PHFSA) 1998. FPMPAM contends that the PHFSA 1998 is the primary governing law for medical practices, including pricing, while the application of the Price Control and Anti-Profiteering Act 2011 to these services is inappropriate and creates confusion. This creates a situation where two distinct laws appear to dictate pricing regulations for medical services.
Concerns Over Sustainability and Regulatory Overlap

The FPMPAM has expressed deep disappointment, stating that the mandatory price display is both inappropriate and detrimental to the sustainability of private primary care. They argue that the imposition of such rules, particularly under legislation not designed for healthcare services, leads to overregulation. This regulatory overlap, they believe, poses a significant threat to the viability of GP practices, necessitating a thorough legal examination of the government's mandate.

Reading history

Hide →

This history is cleared when the page is closed.

What legal challenges might GPs pursue over price display rules?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends